Émilie Brotin

1.2k total citations
34 papers, 840 citations indexed

About

Émilie Brotin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Émilie Brotin has authored 34 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Émilie Brotin's work include Cell death mechanisms and regulation (8 papers), MicroRNA in disease regulation (7 papers) and RNA Interference and Gene Delivery (6 papers). Émilie Brotin is often cited by papers focused on Cell death mechanisms and regulation (8 papers), MicroRNA in disease regulation (7 papers) and RNA Interference and Gene Delivery (6 papers). Émilie Brotin collaborates with scholars based in France, Luxembourg and United States. Émilie Brotin's co-authors include Laurent Poulain, Pascal Gauduchon, Christophe Denoyelle, Matthieu Meryet‐Figuière, Edwige Abeilard, Florence Giffard, Bernard Lambert, Nicolas Vigneron, Marie Villedieu and Françoise Bachelerie and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Émilie Brotin

34 papers receiving 831 citations

Peers

Émilie Brotin

ONCOL

IMMUN

PFM

Monideepa Roy United States

Yunping Lu China

Markus Duechler Poland

Andrea Kinner Germany

Daniel E. Bassi United States

Hyang Sook Seol South Korea

Jiang Ren China

Wai Gin Fong Canada

С. В. Вторушин Russia

Monideepa Roy United States

Émilie Brotin

779 ×1.5

113 ×0.4

251 ×1.1

ONCOL

69 ×0.4

IMMUN

58 ×0.8

PFM

Citations per year, relative to Émilie Brotin Émilie Brotin (= 1×) peers Monideepa Roy

Countries citing papers authored by Émilie Brotin

Since Specialization

Citations

This map shows the geographic impact of Émilie Brotin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Émilie Brotin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Émilie Brotin more than expected).

Fields of papers citing papers by Émilie Brotin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Émilie Brotin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Émilie Brotin. The network helps show where Émilie Brotin may publish in the future.

Co-authorship network of co-authors of Émilie Brotin

This figure shows the co-authorship network connecting the top 25 collaborators of Émilie Brotin. A scholar is included among the top collaborators of Émilie Brotin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Émilie Brotin. Émilie Brotin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bastit, Vianney, Nicolas Elie, Émilie Brotin, et al.. (2025). Use of patient-derived tumor organoids from head and neck squamous cell carcinoma for the evaluation of the differential effect of carbon ions over X-rays. Radiotherapy and Oncology. 210. 111026–111026. 1 indexed citations

Benmoussa, Abderrahim, Émilie Brotin, Françoise Rédiní, et al.. (2023). MiR-4270 acts as a tumor suppressor by directly targeting Bcl-xL in human osteosarcoma cells. Frontiers in Oncology. 13. 1220459–1220459. 1 indexed citations

Cuffel, Alexis, Gaëtan Riou, Laetitia Jean, et al.. (2023). Development of optimized cytotoxicity assays for assessing the antitumor potential of CAR-T cells. Journal of Immunological Methods. 525. 113603–113603. 2 indexed citations

Hem, Sonia, Jean Armengaud, Émilie Brotin, et al.. (2021). A Proteomic Study Suggests Stress Granules as New Potential Actors in Radiation-Induced Bystander Effects. International Journal of Molecular Sciences. 22(15). 7957–7957. 7 indexed citations

Ahmad, Mohammad, Pierre‐Marie Morice, Bernard Lambert, et al.. (2021). The lncRNA ‘UCA1’ modulates the response to chemotherapy of ovarian cancer through direct binding to miR‐27a‐5p and control of UBE2N levels. Molecular Oncology. 15(12). 3659–3678. 32 indexed citations

Vernon, Mégane, Bernard Lambert, Matthieu Meryet‐Figuière, et al.. (2020). Functional miRNA Screening Identifies Wide-ranging Antitumor Properties of miR-3622b-5p and Reveals a New Therapeutic Combination Strategy in Ovarian Tumor Organoids. Molecular Cancer Therapeutics. 19(7). 1506–1519. 23 indexed citations

Hem, Sonia, Christine Almunia, Jean Armengaud, et al.. (2020). Proteomic analysis of bystander effects in chondrosarcoma cells. HAL (Le Centre pour la Communication Scientifique Directe). 1 indexed citations

Groo, Anne‐Claire, Marc Since, Émilie Brotin, et al.. (2020). Pyridoclax-loaded nanoemulsion for enhanced anticancer effect on ovarian cancer. International Journal of Pharmaceutics. 587. 119655–119655. 16 indexed citations

Sauvage, Félix, Elias Fattal, Walhan Alshaer, et al.. (2018). Antitumor activity of nanoliposomes encapsulating the novobiocin analog 6BrCaQ in a triple-negative breast cancer model in mice. Cancer Letters. 432. 103–111. 17 indexed citations

10.

Meryet‐Figuière, Matthieu, Charlotte Lecerf, Jean‐Luc Coll, et al.. (2017). Atelocollagen-mediated in vivo siRNA transfection in ovarian carcinoma is influenced by tumor site, siRNA target and administration route. Oncology Reports. 38(4). 1949–1958. 5 indexed citations

11.

Pionnier, Nicolas, Émilie Brotin, Grégory Karadjian, et al.. (2016). Neutropenic Mice Provide Insight into the Role of Skin-Infiltrating Neutrophils in the Host Protective Immunity against Filarial Infective Larvae. PLoS neglected tropical diseases. 10(4). e0004605–e0004605. 28 indexed citations

12.

Lambert, Bernard, Florence Giffard, Edwige Abeilard, et al.. (2015). Calcium signals inhibition sensitizes ovarian carcinoma cells to anti-Bcl-xL strategies through Mcl-1 down-regulation. APOPTOSIS. 20(4). 535–550. 21 indexed citations

13.

Villedieu, Marie, Émilie Brotin, Marie-Hélène Louis, et al.. (2014). PI3K/mTOR dual inhibitor NVP-BEZ235 decreases Mcl-1 expression and sensitizes ovarian carcinoma cells to Bcl-xL-targeting strategies, provided that Bim expression is induced. Cancer Letters. 348(1-2). 38–49. 43 indexed citations

14.

Malzert‐Fréon, Aurélie, Florence Giffard, Émilie Brotin, et al.. (2013). Sensitization of ovarian carcinoma cells to Bcl-xL-targeting strategies through indirect modulation of Mcl-1 activity by MR22388, a molecule of the tripentone family. Journal of Ovarian Research. 6(1). 38–38. 4 indexed citations

15.

N’Diaye, Monique, Stéphanie Lheureux, Soizic Dutoit, et al.. (2013). Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis. APOPTOSIS. 18(4). 492–508. 35 indexed citations

16.

Bouchery, Tiffany, Tarik Attout, Muriel Hachet‐Haas, et al.. (2012). The Chemokine CXCL12 Is Essential for the Clearance of the Filaria Litomosoides sigmodontis in Resistant Mice. PLoS ONE. 7(4). e34971–e34971. 15 indexed citations

17.

Brotin, Émilie, Laëtitia Carthagéna, Ken Y.C. Chow, & Françoise Bachelerie. (2011). La chimiokine CXCL12 et le papillomavirus humain. médecine/sciences. 27(4). 341–343. 1 indexed citations

18.

Denoyelle, Christophe, Émilie Brotin, Matthieu Meryet‐Figuière, et al.. (2010). Downregulation of Bcl-x L and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy. Carcinogenesis. 31(6). 984–993. 58 indexed citations

19.

Brotin, Émilie, Matthieu Meryet‐Figuière, Raphaël E. Duval, et al.. (2009). Bcl‐X_L and MCL‐1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis. International Journal of Cancer. 126(4). 885–895. 86 indexed citations

20.

Villedieu, Marie, Marie-Hélène Louis, Soizic Dutoit, et al.. (2007). Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells☆. Gynecologic Oncology. 105(1). 31–44. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact